Velan Capital Investment Management LP Collegium Pharmaceutical, Inc Transaction History

Velan Capital Investment Management LP

  • $48.3 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$23.0 - $29.88 $514,119 - $667,907
-22,353 Reduced 50.29%
22,095 $530,000
Q4 2022

Feb 13, 2023
BUY
$16.14 - $23.55 $72,484 - $105,763
4,491 Added 11.24%
44,448 $1.03 Million
Q3 2022

Nov 14, 2022
BUY
$15.46 - $20.1 $617,735 - $803,135
39,957 New
39,957 $640,000

Others Institutions Holding COLL

# of Institutions
249
Shares Held
36.2M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email